September 19, 2023 12:09 PM EDT

MarketingRx roundup: Abbott teams with WeightWatchers for glucose monitoring; Haleon’s Advil starts ‘pain equity’ effort

Beth Snyder Bulik

Senior Editor

Abbott is partnering with WeightWatchers (WW) to help dieters with type 2 diabetes better track their glucose levels. WW members can now access the data …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

MarketingRx roundup: Abbott teams with WeightWatchers for glucose monitoring; Haleon’s Advil starts ‘pain equity’ effort

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Jazz wins approval for bispecific in biliary tract cancer

RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try

FDA adcomm raises risk questions on AstraZeneca’s Andexxa

Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B

At Jefferies, all that manufacturers want to talk about is GLP-1s

Are programs with compounded GLP-1s safe for your population?

Mar­ket­ingRx roundup: Ab­bott teams with Weight­Watch­ers for glu­cose mon­i­tor­ing; Ha­le­on’s Advil starts ‘pain eq­ui­ty’ ef­fort

Beth Snyder Bulik

Senior Editor

Sign up to read this article for free.

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

MarketingRx roundup: Abbott teams with WeightWatchers for glucose monitoring; Haleon’s Advil starts ‘pain equity’ effort

Jazz wins approval for bispecific in biliary tract cancer

RFK Jr. and Elon Musk want to ban pharma ads. They wouldn't be the first to try

FDA adcomm raises risk questions on AstraZeneca’s Andexxa

Novartis seeks more bolt-on deals as it purchases neuro startup for up to $1.1B

At Jefferies, all that manufacturers want to talk about is GLP-1s

Are programs with compounded GLP-1s safe for your population?